Literature DB >> 35790599

LncRNA MALAT1-related signaling pathways in osteosarcoma.

Maryam Farzaneh1, Sajad Najafi2, Omid Anbiyaee3, Shirin Azizidoost4, Seyed Esmaeil Khoshnam5.   

Abstract

Osteosarcoma (OS) is a common and malignant form of bone cancer, which affects children and young adults. OS is identified by osteogenic differentiation and metastasis. However, the exact molecular mechanism of OS development and progression is still unclear. Recently, long non-coding RNAs (lncRNA) have been proven to regulate OS proliferation and drug resistance. LncRNAs are longer than 200 nucleotides that represent the extensive applications in the processing of pre-mRNA and the pathogenesis of human diseases. Metastasis-associated lung adenocarcinoma transcript-1 (MALAT1) is a well-known lncRNA known as a transcriptional and translational regulator. The aberrant expression of MALAT1 has been shown in several human cancers. The high level of MALAT1 is involved in OS cell growth and tumorigenicity by targeting several signaling pathways and miRNAs. Hence, MALAT1 might be a suitable approach for OS diagnosis and treatment. In this review, we will summarize the role of lncRNA MALAT1 in the pathophysiology of OS.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  Long non-coding RNAs; MALAT1; Osteosarcoma; Signaling pathways; miRNAs

Year:  2022        PMID: 35790599     DOI: 10.1007/s12094-022-02876-x

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.340


  72 in total

Review 1.  An update on chemotherapy for osteosarcoma.

Authors:  Stefano Ferrari; Massimo Serra
Journal:  Expert Opin Pharmacother       Date:  2015-10-29       Impact factor: 3.889

2.  Genome-Informed Targeted Therapy for Osteosarcoma.

Authors:  Leanne C Sayles; Marcus R Breese; Amanda L Koehne; Stanley G Leung; Alex G Lee; Heng-Yi Liu; Aviv Spillinger; Avanthi T Shah; Bogdan Tanasa; Krystal Straessler; Florette K Hazard; Sheri L Spunt; Neyssa Marina; Grace E Kim; Soo-Jin Cho; Raffi S Avedian; David G Mohler; Mi-Ok Kim; Steven G DuBois; Douglas S Hawkins; E Alejandro Sweet-Cordero
Journal:  Cancer Discov       Date:  2018-09-28       Impact factor: 39.397

3.  Biomarkers in Osteosarcoma.

Authors:  Colin Kong; Marc F Hansen
Journal:  Expert Opin Med Diagn       Date:  2009-01-01

4.  One-stop radiotherapeutic targeting of primary and distant osteosarcoma to inhibit cancer progression and metastasis using 2DG-grafted graphene quantum dots.

Authors:  Fu-I Tung; Lu-Jun Zheng; Kai-Ting Hou; Chih-Sheng Chiang; Ming-Hong Chen; Tse-Ying Liu
Journal:  Nanoscale       Date:  2020-04-30       Impact factor: 7.790

5.  Osteosarcoma.

Authors:  Bree R Eaton; Rudolf Schwarz; Ralph Vatner; Brian Yeh; Line Claude; Daniel J Indelicato; Nadia Laack
Journal:  Pediatr Blood Cancer       Date:  2020-08-11       Impact factor: 3.167

Review 6.  What is the best clinical approach to recurrent/refractory osteosarcoma?

Authors:  Cristina Meazza; Stefano Bastoni; Paolo Scanagatta
Journal:  Expert Rev Anticancer Ther       Date:  2020-05-07       Impact factor: 4.512

Review 7.  Osteosarcoma Overview.

Authors:  Brock A Lindsey; Justin E Markel; Eugenie S Kleinerman
Journal:  Rheumatol Ther       Date:  2016-12-08

Review 8.  MicroRNA let-7 and viral infections: focus on mechanisms of action.

Authors:  Arash Letafati; Sajad Najafi; Mehran Mottahedi; Mohammad Karimzadeh; Ali Shahini; Setareh Garousi; Mohammad Abbasi-Kolli; Javid Sadri Nahand; Seyed Saeed Tamehri Zadeh; Michael R Hamblin; Neda Rahimian; Mohammad Taghizadieh; Hamed Mirzaei
Journal:  Cell Mol Biol Lett       Date:  2022-02-14       Impact factor: 5.787

Review 9.  Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment.

Authors:  Lavinia Raimondi; Angela De Luca; Viviana Costa; Nicola Amodio; Valeria Carina; Daniele Bellavia; Pierfrancesco Tassone; Stefania Pagani; Milena Fini; Riccardo Alessandro; Gianluca Giavaresi
Journal:  Oncotarget       Date:  2017-08-03

Review 10.  Novel molecular insights and new therapeutic strategies in osteosarcoma.

Authors:  Babak Otoukesh; Bahram Boddouhi; Mehdi Moghtadaei; Peyman Kaghazian; Maria Kaghazian
Journal:  Cancer Cell Int       Date:  2018-10-16       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.